Medicare Enrolled

Dr. Rebecca Mantsch, DO

Cytopathology Physician · Odessa, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
500 W 4TH ST, Odessa, TX 79761
4326401330
In practice since 2007 (18 years)
NPI: 1528281441 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mantsch from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mantsch? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mantsch

Dr. Rebecca Mantsch is a cytopathology physician in Odessa, TX, with 18 years of NPI registration. Based on federal Medicare data, Dr. Mantsch performed 456 Medicare services across 309 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mantsch received a total of $146 from 1 pharmaceutical and/or device company across 3 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cytopathology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mantsch is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ 456 Medicare services $146 industry payments

Medicare Practice Summary

Medicare Utilization ↗
456
Medicare services
Bottom 19% in TX for cytopathology physician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
309
Unique beneficiaries
$25
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~25 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Tissue staining for diagnosis, additional 95 $22 $75
Tissue staining for diagnosis, initial 73 $27 $94
Cell examination of specimen, selective cellular enhancement technique 66 $21 $74
Pathology examination of tissue using a microscope, moderately low complexity 48 $8 $31
Pathology examination of tissue using a microscope, moderately high complexity 44 $64 $219
Preparation of tissue for examination by removing any calcium present 42 $9 $34
Special stained specimen slides to examine tissue including interpretation and report 36 $9 $32
Blood bank physician services with written report 20 $39 $130
Pathology cytologic examination of specimen during surgery, initial site 19 $48 $166
Tissue pathology examination, moderate complexity 13 $22 $100
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
4.2% high complexity
0.0% medium
95.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$146
Total received (2023-2024)
Avg $73/year across 2 years
Top 42% in TX for cytopathology physician
1
Company
3
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$146 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$17
2023
$129

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Merck Sharp & Dohme LLC
$146
Top 3 companies account for 100.0% of total payments
Associated products mentioned in payments ›
KEYTRUDA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $32 per 100 Medicare services performed
Looking for a cytopathology physician in Odessa?
Compare cytopathology physicians in the Odessa area by procedure volume, costs, and industry payment transparency.
Browse cytopathology physicians nearby

Geographic Context

Cytopathology physicians within 10 mi
2
Per 100K population
1.2
County median income
$71,031
Nearest hospital
MEDICAL CENTER HOSPITAL
0.0 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Mantsch is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 18 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Mantsch experienced with tissue staining for diagnosis, additional?
Based on Medicare claims data, Dr. Mantsch performed 95 tissue staining for diagnosis, additional services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mantsch receive payments from pharmaceutical companies?
Yes. Dr. Mantsch received a total of $146 from 1 company across 3 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mantsch's costs compare to other cytopathology physicians in Odessa?
Dr. Mantsch's average Medicare payment per service is $25. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mantsch) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Cytopathology Physicians in Odessa
Browse cytopathology physicians in Odessa ranked by procedure volume and transparency data.
Highest volume
Top Cytopathology Physicians in TX
Cytopathology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cytopathology Physicians in TX
Which TX cytopathology physicians receive the most from drug and device companies.
By company
Merck Sharp & Dohme LLC Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme LLC.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →